Not an SEC registrant

Bioaegis Therapeutics INC

Customers

1 federal agency

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Federal obligations

$20.0M

FY2023 · USAspending.gov

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Federal contracts 1

Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $20.0M in the latest fiscal year shown per agency.

Agency	Obligated	Fiscal year	Awards	Trend	Largest award
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	$20.0M	FY 2023	2		75A50123C00067
BIOAEGIS: PLASMA GELSOLIN (PGSN), AN ABUNDANT, CIRCULATING PROTEIN MODULATES INFLAMMATION WHILE ALSO ENHANCING HOST DEFENSES BY STIMULATING THE UPTAKE AND KILLING OF PATHOGENS. CLINICAL STUDIES HAVE CONSISTENTLY SHOWN PGSN IS DEPLETED IN SEVERE I Award 75A50123C00067 on USAspending.gov ↗ Largest of 2 awards in FY2023: $20.0M obligated

Alerts are coming

Get an email when Bioaegis Therapeutics INC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.